Biosimilars

Latest News

Q&A: A Closer Look at the Current State of Biosimilars in the Drug Market
Q&A: A Closer Look at the Current State of Biosimilars in the Drug Market

November 28th 2024

Steve Callahan, Senior Director of Advisory & Insights at MMIT, sat down with Drug Topics to discuss industry trends behind biosimilars.

Denosumab Cost Effectiveness Varies in Postmenopausal Osteoporosis | AMCP Nexus 2024
Denosumab Cost Effectiveness Varies in Postmenopausal Osteoporosis | AMCP Nexus 2024

October 25th 2024

FDA Approves Imuldosa, Biosimilar to Stelara
FDA Approves Imuldosa, Biosimilar to Stelara

October 11th 2024

FDA Approval Marks Epysqli as Second Soliris Biosimilar
FDA Approval Marks Epysqli as Second Soliris Biosimilar

July 22nd 2024

Boehringer Ingelheim and GoodRx Partner to Offer Major Discount on Adalimumab-adbm
Boehringer Ingelheim and GoodRx Partner to Offer Major Discount on Adalimumab-adbm

July 18th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.